Current role
Jacqueline Zummo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Protara Therapeutics, Inc. (TARA)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Protara Therapeutics, Inc. (TARA) | Chief R&D Officer | $494,000 | $1,382,274 |
| 2024 | Protara Therapeutics, Inc. (TARA) | Chief Scientific Operations Officer | $475,755 | $1,214,189 |
| 2023 | Protara Therapeutics, Inc. (TARA) | Chief Scientific Operations Officer | $432,446 | $1,039,848 |
| 2022 | Protara Therapeutics, Inc. (TARA) | Chief Scientific Operations Officer | $417,835 | $1,301,718 |
| 2021 | Protara Therapeutics, Inc. (TARA) | Chief Scientific Operations Officer | $405,444 | $1,787,078 |
| 2020 | Protara Therapeutics, Inc. (TARA) | Chief Scientific Operations Officer | $324,927 | $1,991,181 |
| 2019 | Protara Therapeutics, Inc. (TARA) | Ph.D., MPH, MBA Chief Scientific Operations Officer | $289,425 | $353,652 |
| 2018 | Protara Therapeutics, Inc. (TARA) | Ph.D., MPH, MBA Senior Vice President, Research Operations | $185,158 | $450,704 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.